StructoKabiven Infusionsemulsion

Država: Švica

Jezik: italijanščina

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Aktivna sestavina:

glucosum anhydricum, triglycerida, aminoacida, carbohydrata, materia crassa, natrium, kalium, magnesium, calcium, phosphas, zincum, sulfas, chloridum, acetas, alaninum, argininum, glycinum, histidinum, isoleucinum, leucinum, lysinum anhydricum, methioninum, phenylalaninum, prolinum, serinum, taurinum, threoninum, tryptophanum, tyrosinum, valinum, calcii chloridum dihydricum, natrii glycerophosphas, magnesii sulfas anhydricus, kalii chloridum, natrii acetas anhydricus, zinci sulfas anhydricus

Dostopno od:

Fresenius Kabi (Schweiz) AG

Koda artikla:

B05BA10

INN (mednarodno ime):

glucosum anhydricum, triglycerida, aminoacida, carbohydrata, materia crassa, natrium, kalium, magnesium, calcium, phosphas, zinc

Farmacevtska oblika:

Infusionsemulsion

Sestava:

I) Glucoselösung: glucosum anhydricum 125 g ut glucosum monohydricum, aqua ad iniectabilia q.s. ad solutionem pro 298 ml. II) Aminosäurelösung mit Elektrolyten: alaninum 7 g, argininum 6 g, glycinum 5.5 g, histidinum 1.5 g, isoleucinum 2.5 g, leucinum 3.7 g, lysinum anhydricum 3.3 g ut lysini acetas, methioninum 2.15 g, phenylalaninum 2.55 g, prolinum 5.6 g, serinum 3.25 g, taurinum 0.5 g, threoninum 2.2 g, tryptophanum 1 g, tyrosinum 0.2 g, valinum 3.1 g, calcii chloridum dihydricum 370 mg, natrii glycerophosphas 2.09 g, magnesii sulfas anhydricus 600 mg ut magnesii sulfas heptahydricus, kalii chloridum 2.24 g, natrii acetas anhydricus 1.7 g ut natrii acetas trihydricus, zinci sulfas anhydricus 6.45 mg ut zinci sulfas heptahydricum, aqua ad iniectabilia q.s. ad solutionem pro 500 ml. III) Fettemulsion: triglycerida 37.6 g, phospholipida purificata ex ovo, glycerolum 4.136 g, aqua ad iniectabilia q.s. ad emulsionem pro 188 ml. I) et II) et III) corresp.: aminoacida 51 g/l, carbohydrata 127 g/l, materia crassa

Terapevtska skupina:

Synthetika human

Terapevtsko območje:

Parenterale Ernährung

Datum dovoljenje:

2005-03-24